Form 10-K405 - Annual report [Sections 13 and 15(d), S-K Item 405]:
SEC Accession No. 0000893220-99-001117
Filing Date
1999-09-28
Accepted
1999-09-28 00:00:00
Documents
5
Period of Report
1999-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-K FISCAL YEAR ENDED JUNE 30, 1999 10-K405 208218
2 EMPLOYMENT AGREEMENT EX-10.6 21879
3 CONSENT OF KPMG LLP EX-23.1 811
4 CONSENT OF RICHARD A. EISNER & COMPANY LLP EX-23.2 813
5 FINANCIAL DATA SCHEDULE EX-27 2474
  Complete submission text file 0000893220-99-001117.txt   236189
Mailing Address 425 PARK AVE 27TH FL NEW YORK NY 10022
Business Address 425 PARK AVE 27TH FL NEW YORK NY 10022 2123198300
INKINE PHARMACEUTICAL CO INC (Filer) CIK: 0000929547 (see all company filings)

EIN.: 133754005 | State of Incorp.: NY | Fiscal Year End: 0630
Type: 10-K405 | Act: 34 | File No.: 000-25572 | Film No.: 99719181
SIC: 2834 Pharmaceutical Preparations